...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: AHA late breaking abstract

Yes, this is correct. The trial will have been accepted for presentation on the basis of its design, conduct, and importance. It was well designed (approved by the FDA); it was well conducted; and the results are very important, clinically and scientifically, whether positive or negative. 

Share
New Message
Please login to post a reply